GlassScriptPhysician profile
David N Cohen
NPI 1184955767
$36,500.43
in general payments reported to CMS, 2019-2025
30 companies · $2,324 in 2025
The $2,324 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $4,007 · 2021: $2,455 · 2022: $1,875 · 2023: $5,014 · 2024: $4,535 · 2025: $2,324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,102 · Travel and Lodging: $5,770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,102.46 |
| Travel and Lodging | $5,769.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $29,172.02 | 2019-2025 | Aveir, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Medtronic, INC. | $2,808.99 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $1,646.23 | 2019-2025 | General - Tachy, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Novartis Pharmaceuticals Corporation | $433.95 | 2019-2025 | |
| Biotronik INC. | $398.50 | 2019-2023 | Acticor 7 Vr-T Dx, Biomonitor |
| Acutus Medical, INC. | $336.85 | 2021-2022 | |
| Intuitive Surgical, INC. | $286.61 | 2019 | |
| Janssen Pharmaceuticals, INC | $183.45 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $119.20 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $112.11 | 2019-2022 | |
| Amgen INC. | $106.23 | 2020-2025 | Repatha |
| Medtronic Vascular, INC. | $94.90 | 2019-2020 | |
| Pfizer INC. | $94.59 | 2019-2023 | |
| Cardiva Medical, INC. | $84.01 | 2022 | |
| Janssen Biotech, INC. | $71.39 | 2025 | Tremfya |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $66.57 | 2021 | |
| Circa Scientific, INC. | $62.50 | 2021 | |
| Philips North America LLC | $53.12 | 2022-2024 | (9148) Ice 3d |
| Merck Sharp & Dohme LLC | $52.25 | 2021-2023 | Verquvo |
| Impulse Dynamics (USA) INC. | $43.02 | 2025 | Optimizer |
| Novo Nordisk INC | $42.64 | 2022-2024 | Ozempic, Rybelsus |
| Cvrx, INC. | $34.06 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $33.13 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $32.41 | 2019-2020 | |
| Stryker Corporation | $31.15 | 2025 | Flowtriever |
| Kestra Medical Technology Services, INC. | $28.64 | 2024 | Assure Wcd |
| Irhythm Technologies, INC. | $24.54 | 2023 | Zio Xt Patch |
| Baxter Healthcare | $16.53 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Celgene Corporation | $16.36 | 2023 | Camzyos |
| Lantheus Medical Imaging, INC. | $14.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.